Erratum. Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254–2261

12 januari 2022
door American Diabetes Association - Care

The article cited above outlines the details of the then-upcoming Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) clinical trial, but it was not linked to the GRADE ClinicalTrials.gov identifier. The GRADE ClinicalTrials.gov identifier is NCT01794143.

Bekijk het originele bericht

Erratum. Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254–2261

Wellicht vindt u dit ook interessant

Meld u aan voor de maandelijkse nieuwsbrief

Categorieën

Patiëntvoorbeelden m.b.t. vergoeding

Voeg je koptekst hier toe

Vergoeding diabetesmiddelen